ER+/HER2+ Metastatic Breast Cancer
2 vistas
• 07/03/23
0
0
Empotrar
administrator
Suscriptores
Hope S. Rugo, MD, looks at the use of CDK4/6 inhibitors for patients with metastatic ER-positive, HER2-positive breast cancer and the trials evaluating their use in this setting.
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios